Advertisement

Citation tools

Salles, Gilles et al "Phase 1 study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody obinutuzumab (GA101) in B-cell lymphoma patients." Blood 119.22 (2012): 5126-5132. Web. 20 Aug. 2019.